Anti-HPA-1b Mediated Posttransfusion Purpura: A Case Report

Posttransfusion purpura (PTP) is an uncommon, but potentially fatal, transfusion reaction characterized by profound thrombocytopenia and bleeding. PTP is caused by alloimmunization to human platelet specific antigens following blood component transfusion. Although there is evidence of a wide serolog...

Full description

Bibliographic Details
Main Authors: O. P. Arewa, S. Nahirniak, G. Clarke
Format: Article
Language:English
Published: Hindawi Limited 2013-01-01
Series:Case Reports in Medicine
Online Access:http://dx.doi.org/10.1155/2013/568364
id doaj-41fac32d170c44f0bb4ad7d78c3afb4c
record_format Article
spelling doaj-41fac32d170c44f0bb4ad7d78c3afb4c2020-11-24T23:15:50ZengHindawi LimitedCase Reports in Medicine1687-96271687-96352013-01-01201310.1155/2013/568364568364Anti-HPA-1b Mediated Posttransfusion Purpura: A Case ReportO. P. Arewa0S. Nahirniak1G. Clarke2Department of Laboratory Medicine & Blood Bank, Arar Central Hospital, Arar, Saudi ArabiaDepartment of Laboratory Medicine & Pathology, University of Alberta Hospital, Edmonton, AB, CanadaDepartment of Laboratory Medicine & Pathology, University of Alberta Hospital, Edmonton, AB, CanadaPosttransfusion purpura (PTP) is an uncommon, but potentially fatal, transfusion reaction characterized by profound thrombocytopenia and bleeding. PTP is caused by alloimmunization to human platelet specific antigens following blood component transfusion. Although there is evidence of a wide serological spectrum of culprit antibodies implicated, Anti-human-platelet-antigen- (HPA-) 1a is the most common antibody in cases reported. We report a case of posttransfusion purpura in an African American. The patient was negative for HPA-1a antibodies, but anti-HPA-1b was identified with a platelet phenotype of HPA-1a/HPA-1a. Although less common, HPA-1b antibody may be an important consideration in posttransfusion purpura diagnosed in patients of African descent.http://dx.doi.org/10.1155/2013/568364
collection DOAJ
language English
format Article
sources DOAJ
author O. P. Arewa
S. Nahirniak
G. Clarke
spellingShingle O. P. Arewa
S. Nahirniak
G. Clarke
Anti-HPA-1b Mediated Posttransfusion Purpura: A Case Report
Case Reports in Medicine
author_facet O. P. Arewa
S. Nahirniak
G. Clarke
author_sort O. P. Arewa
title Anti-HPA-1b Mediated Posttransfusion Purpura: A Case Report
title_short Anti-HPA-1b Mediated Posttransfusion Purpura: A Case Report
title_full Anti-HPA-1b Mediated Posttransfusion Purpura: A Case Report
title_fullStr Anti-HPA-1b Mediated Posttransfusion Purpura: A Case Report
title_full_unstemmed Anti-HPA-1b Mediated Posttransfusion Purpura: A Case Report
title_sort anti-hpa-1b mediated posttransfusion purpura: a case report
publisher Hindawi Limited
series Case Reports in Medicine
issn 1687-9627
1687-9635
publishDate 2013-01-01
description Posttransfusion purpura (PTP) is an uncommon, but potentially fatal, transfusion reaction characterized by profound thrombocytopenia and bleeding. PTP is caused by alloimmunization to human platelet specific antigens following blood component transfusion. Although there is evidence of a wide serological spectrum of culprit antibodies implicated, Anti-human-platelet-antigen- (HPA-) 1a is the most common antibody in cases reported. We report a case of posttransfusion purpura in an African American. The patient was negative for HPA-1a antibodies, but anti-HPA-1b was identified with a platelet phenotype of HPA-1a/HPA-1a. Although less common, HPA-1b antibody may be an important consideration in posttransfusion purpura diagnosed in patients of African descent.
url http://dx.doi.org/10.1155/2013/568364
work_keys_str_mv AT oparewa antihpa1bmediatedposttransfusionpurpuraacasereport
AT snahirniak antihpa1bmediatedposttransfusionpurpuraacasereport
AT gclarke antihpa1bmediatedposttransfusionpurpuraacasereport
_version_ 1725589319382466560